Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Myers Industries Stock Surges 13 After Strong Q4 Results and FY24 Guidance

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

Myers Industries has experienced a notable surge of 13% in its stock price since announcing better-than-expected Q4 adjusted EPS results and providing FY24 adjusted EPS guidance that surpasses expectations. As of March 5, 2024, the stock is trading at approximately $19.22.

Myers Industries, Inc. (MYE) is a company based in Ohio that specializes in the distribution of tire service supplies. It operates through two primary segments: Material Handling and Distribution. The company’s financials reveal a market capitalization of around $685.20 million, earnings of $49.76 million, and revenue of $834.83 million. Moreover, Myers Industries boasts a PE ratio of 12.90 and an EPS of 1.34.

Myers Industries Inc. (MYE) Stock Shows Positive Performance and Bullish Momentum in Pre-Market Trading on March 5, 2024

On March 5, 2024, Myers Industries Inc. (MYE) showed positive stock performance as it traded in the middle of its 52-week range and above its 200-day simple moving average. The price of MYE shares increased by $0.20 since the previous market close, representing a 1.04% rise from the last closing price of $19.42.

In pre-market trading, MYE stock continued to show strength as it surged by $1.33, indicating further bullish momentum. This significant increase in pre-market trading suggests that investors are optimistic about the future prospects of Myers Industries Inc.

MYE Stock Shows Strong Performance with Significant Increases in Net Income and EPS

On March 5, 2024, MYE stock showed strong performance based on the financial data provided by CNN Money. The company reported total revenue of $899.55 million for the past year, which represents an 18.14% increase compared to the previous year. However, total revenue for the third quarter was $197.80 million, indicating a 5.11% decrease compared to the previous quarter.

Despite the slight decrease in revenue for the quarter, MYE reported a net income of $60.27 million for the past year, showing a significant increase of 79.7% compared to the previous year. Net income for the third quarter was $12.75 million, which also saw a healthy increase of 20.2% compared to the previous quarter.

Earnings per share (EPS) for MYE stock were reported at $1.64 for the past year, which represents a substantial increase of 77.59% compared to the previous year. EPS for the third quarter was $0.34, showing a solid increase of 19.9% compared to the previous quarter.

Overall, MYE stock demonstrated strong financial performance on March 5, 2024, with increases in net income and EPS compared to both the previous year and the previous quarter. Investors may view these positive financial indicators as a sign of the company’s growth and profitability.

Tags: MYE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
IT-Healthcare

Title Launch of KARDIA3 Trial Evaluating Zilebesiran for Uncontrolled Hypertension

Biopharmaceutical

Exciting Progress for BI1206 in NonHodgkins Lymphoma Treatment

Groundbreaking Data on GT02287 A Potential Treatment for Parkinsons Disease

Recommended

OHI stock news

Bel Fuse Director Sells 56700 Worth of Shares Amid Financial Challenges

2 years ago
I-Mab Stock

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

5 months ago
Nvidia Stock

Nvidia’s Key Supplier Signals Unwavering AI Demand

2 months ago
Silber Stock

Silver’s Perfect Storm: A Market Poised for Breakout

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Trending

SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

by Kennethcix
March 25, 2026
0

The semiconductor industry finds itself navigating a complex landscape where geopolitical developments intersect with tangible supply chain...

Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com